On ECHEMI
Home > Drugs > NCPC Genetech BIOTECHNOLOGY Co., Ltd.
NCPC Genetech BIOTECHNOLOGY Co., Ltd.
  • Founded in:

    2002-04-02
  • Country:

    China China
  • Address:

    No. 106, Tianshan South Street, Shijiazhuang High-tech Zone
  • Tax NO.:

    91130000601703350Y
  • Registered Funds:

    185.051637 yuan
  • Website:

  • Email:

Related Drugs
Recombinant Hepatitis B Vaccine (CHO Cells)
This product is made from hepatitis B virus surface antigen (HBsAg) expressed by recombinant CHO cells, which is purified and adsorbed with adjuvants for the prevention of hepatitis B.
Name Description Content CAS NO. Registered Holders
HBSAG

Hepatitis B surface antigen can stimulate antibody-forming cells in the human body to produce antibodies that neutralize hepatitis B virus and can be used to prevent hepatitis B virus infection.

More

Hepatitis B surface antigen can stimulate antibody-forming cells in the human body to produce antibodies that neutralize hepatitis B virus and can be used to prevent hepatitis B virus infection.

0
Recombinant Hepatitis B Vaccine (CHO Cells)
This product is made from hepatitis B virus surface antigen (HBsAg) expressed by recombinant CHO cells, which is purified and adsorbed with adjuvants for the prevention of hepatitis B.
Name Description Content CAS NO. Registered Holders
HBSAG

Hepatitis B surface antigen can stimulate antibody-forming cells in the human body to produce antibodies that neutralize hepatitis B virus and can be used to prevent hepatitis B virus infection.

More

Hepatitis B surface antigen can stimulate antibody-forming cells in the human body to produce antibodies that neutralize hepatitis B virus and can be used to prevent hepatitis B virus infection.

0
Recombinant Hepatitis B Vaccine (CHO Cells)
This product is made from hepatitis B virus surface antigen (HBsAg) expressed by recombinant CHO cells, which is purified and adsorbed with adjuvants for the prevention of hepatitis B.
Name Description Content CAS NO. Registered Holders
HBSAG

Hepatitis B surface antigen can stimulate antibody-forming cells in the human body to produce antibodies that neutralize hepatitis B virus and can be used to prevent hepatitis B virus infection.

More

Hepatitis B surface antigen can stimulate antibody-forming cells in the human body to produce antibodies that neutralize hepatitis B virus and can be used to prevent hepatitis B virus infection.

0
Recombinant human erythropoietin injection (CHO cells)
Main ingredients: Recombinant human erythropoietin.
Name Description Content CAS NO. Registered Holders
Erythropoietin

Erythropoietin is an active glycoprotein secreted by the kidneys. It acts on erythroid hematopoietic progenitor cells in the bone marrow and promotes their proliferation and differentiation. This product can induce a significant effect of stimulating colony formation through late-stage mother erythroid progenitor cells (CFUE). At high concentrations, this product can also stimulate early-stage mother erythroid progenitor cells (BFUE) to induce colony formation.

More

Erythropoietin is an active glycoprotein secreted by the kidneys. It acts on erythroid hematopoietic progenitor cells in the bone marrow and promotes their proliferation and differentiation. This product can induce a significant effect of stimulating colony formation through late-stage mother erythroid progenitor cells (CFUE). At high concentrations, this product can also stimulate early-stage mother erythroid progenitor cells (BFUE) to induce colony formation.

11096-26-7 0
Xunke
Active ingredient: Olimtegravir, a recombinant human anti-rabies virus monoclonal antibody expressed in Chinese hamster ovary cells. Excipients: glycine, histidine, mannitol, polysorbate 80, edetate disodium, water for injection.
Name Description Content CAS NO. Registered Holders
Ormutivimab

Recombinant human anti-rabies virus monoclonal antibody can specifically neutralize rabies virus and play a passive immunization role. Non-clinical studies have shown that this product can produce a clear protective effect on animals exposed to rabies virus.

More

Recombinant human anti-rabies virus monoclonal antibody can specifically neutralize rabies virus and play a passive immunization role. Non-clinical studies have shown that this product can produce a clear protective effect on animals exposed to rabies virus.

2449086-91-1 0
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.